|
⚲
|
| Keyboard |
| Lindblom Christopher M
✚
|
|
|---|---|
| CIK # | 0001378796 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001378796] | |
| 4 | [0001378796] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Infinity Pharmaceuticals Inc | |
| Lindblom Christopher M | |
| DNIB Unwind Inc | |
| Tempest Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Infinity Pharmaceuticals Inc INFI
Stock Option (right to buy) · derivative
|
2016-05-02 | Grant | 40,000 | $0.00 | |
|
DNIB Unwind Inc BIND
Employee Stock Option (Right to Buy) · derivative
|
2015-03-07 | Grant | 45,000 | $0.00 | |
|
Tempest Therapeutics Inc OVAS
Stock Option (right to buy) · derivative
|
2013-06-07 | Grant | 93,846 | $0.00 | |
|
Infinity Pharmaceuticals Inc INFI
Stock Option (right to buy) · derivative
|
2013-01-04 | Grant | 14,941 | $0.00 | |
|
Infinity Pharmaceuticals Inc INFI
Stock Option (right to buy) · derivative
|
2012-11-26 | Option exercise | 3,885 | $0.00 | |
|
Infinity Pharmaceuticals Inc INFI
Stock Option (right to buy) · derivative
|
2012-11-26 | Option exercise | 10,000 | $0.00 | |
|
Infinity Pharmaceuticals Inc INFI
Common Stock
|
2012-11-26 | Option exercise | 10,000 | $14.33 | 143,300 |
|
Infinity Pharmaceuticals Inc INFI
Common Stock
|
2012-11-26 | Sell | 13,885 | $25.73 | 357,261 |
|
Infinity Pharmaceuticals Inc INFI
Common Stock
|
2012-11-26 | Option exercise | 3,885 | $9.80 | 38,073 |
|
Infinity Pharmaceuticals Inc INFI
Stock Option (right to buy) · derivative
|
2012-01-06 | Grant | 30,104 | $0.00 |